ZURICH/LONDON (Reuters) - Swiss drugmaker Roche is paying $2.4 billion to buy the rest of Foundation Medicine (FMI) , raising its bet on the U.S.... ...http://feeds.reuters.com/~r/reuters/INhealth/~3/M6GQB0HiOy8/roche-pays-2-4-billion-for-rest-of-cancer-expert-foundation-medicine-idINKBN1JF0F3
ZURICH (Reuters) - A drug being co-developed by Roche to treat spinal muscular atrophy (SMA) helped improve development scores in babies with the... ...http://feeds.reuters.com/~r/reuters/INhealth/~3/Nx-M4bLY-y0/roche-sma-drug-shines-in-study-as-costly-new-therapies-advance-idINKBN1JE1RZ
Posted by Equitymaster Asian share markets are higher today as Japanese and Hong Kong shares show gains. The Nikkei 225 is up 0.3% while the Hang... ...http://feeds.equitymaster.com/~r/TodaysMarket/~3/53Mo2p5SRXI/tm.asp
ZURICH (Reuters) - Roche has been given fast-track review by the U.S. Food and Drug Administration (FDA) for its Hemlibra treatment for people with... ...http://feeds.reuters.com/~r/reuters/INhealth/~3/0blvoiS3tsg/roche-gets-priority-review-from-fda-for-hemlibra-idINKCN1J10HF
In the ‘Arena of Valour,’ a popular online game, the character Ilumia is a wizard endowed with powers to inflict damage and protect others.... ...https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/sun-rises-with-rd-and-bets-on-specialty-drugs/articleshow/64458050.cms
Roche is a Emerging company as a IVR...